30.27 +1.66 (5.80%)
After hours: 7:20PM EST
Previous Close | 30.05 |
Open | 30.51 |
Bid | 30.27 x 1000 |
Ask | 30.90 x 900 |
Day's Range | 26.16 - 31.74 |
52 Week Range | 26.16 - 71.91 |
Volume | 1,778,912 |
Avg. Volume | 1,153,310 |
Market Cap | 7.701B |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 55.80 |
EMA Advises Use of AbCellera-Discovered Bamlanivimab, Alone or Together with Etesevimab, to Treat Confirmed COVID-19 Patients
In this article we talk about 15 fastest growing biotech companies in the US. You can skip our detailed analysis of the biotech industry and go to 5 Fastest Growing Biotech Companies in the US. Biotechnology is one of the most consequential domains of the healthcare industry. Biotechnology uses biology and the functions of living […]
AbCellera will present at the 10th Annual SVB Leerink Global Healthcare Conference on Thursday, February 25, 2021 at 1:20 p.m. Pacific Time.